Pre-BCR has been suggested to function as a tumor suppressor due to the presence of non-functional IgHM gene rearrangements, thereby allowing leukemic pre-B cells to escape normal differentiation while avoiding the pre-BCR checkpoint27. The gene discussed is BCR; the disease is neoplasm.